Cargando…

Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages

BACKGROUND: Glioblastoma is the most malignant tumor of the central nervous system. Several prediction models have been produced to aid in prognosis assessment. Age, a primary decision factor for prognosis, is associated with increased genomic alterations, however the exact link between increased ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Guanzhang, Zhai, You, Wang, Zheng, Wang, Zhiliang, Huang, Ruoyu, Jiang, Haoyu, Li, Renpeng, Feng, Yuemei, Chang, Yuanhao, Jiang, Tao, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064041/ https://www.ncbi.nlm.nih.gov/pubmed/31851783 http://dx.doi.org/10.1002/cam4.2754

Ejemplares similares

RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastoma
por: Li, Guanzhang, et al.
Publicado: (2020)

Uronic acid metabolic process–related gene expression–based signature predicts overall survival of glioma
por: Feng, Yuemei, et al.
Publicado: (2021)

A novel methylation signature predicts radiotherapy sensitivity in glioma
por: Feng, Yuemei, et al.
Publicado: (2020)

Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis
por: Zhai, You, et al.
Publicado: (2020)

An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas
por: Li, Guanzhang, et al.
Publicado: (2022)

A novel DNA repair‐related nomogram predicts survival in low‐grade gliomas
por: Li, Guanzhang, et al.
Publicado: (2020)

Functional clustering analysis identifies specific subtypes of aldehyde dehydrogenase associated with glioma immunity
por: Wang, Di, et al.
Publicado: (2021)

Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma
por: Chang, Yuanhao, et al.
Publicado: (2020)

Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy
por: Zhao, Zongxing, et al.
Publicado: (2020)

Clinical characteristics and survival of glioblastoma complicated with non-central nervous system tumors
por: Wang, Chen, et al.
Publicado: (2022)

Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy
por: Wang, Kuanyu, et al.
Publicado: (2019)

Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma
por: Wu, Fan, et al.
Publicado: (2018)

Comprehensive Analysis of the Clinical and Biological Significances of Endoplasmic Reticulum Stress in Diffuse Gliomas
por: Huang, Ruoyu, et al.
Publicado: (2021)

Corrigendum: Comprehensive analysis of the clinical and biological significances of endoplasmic reticulum stress in diffuse gliomas
por: Huang, Ruoyu, et al.
Publicado: (2022)

HCK promotes glioblastoma progression by TGFβ signaling
por: Wang, Zhenlin, et al.
Publicado: (2020)

TREM2 is associated with tumor immunity and implies poor prognosis in glioma
por: Yu, Mingchen, et al.
Publicado: (2023)

Bioinformatics analysis of potential core genes for glioblastoma
por: Zhang, Yu, et al.
Publicado: (2020)

Molecular classification of IDH-mutant glioblastomas based on gene expression profiles
por: Wu, Fan, et al.
Publicado: (2019)

Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer
por: Che, Keying, et al.
Publicado: (2020)

Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion
por: Li, Guanzhang, et al.
Publicado: (2021)

Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open‐label phase 2 study
por: Hwang, Kihwan, et al.
Publicado: (2021)

Long-term efficacy of surgical resection with or without adjuvant therapy for treatment of secondary glioblastoma in adults
por: Huang, Ruoyu, et al.
Publicado: (2020)

D2‐resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy
por: Peng, Jin, et al.
Publicado: (2016)

Survival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients
por: Zhang, Maochen, et al.
Publicado: (2020)

A potentially effective drug for patients with recurrent glioma: sermorelin
por: Chang, Yuanhao, et al.
Publicado: (2021)

CD66b(+) neutrophils and α‐SMA(+) fibroblasts predict clinical outcomes and benefits from postoperative chemotherapy in gastric adenocarcinoma
por: Cong, Xiliang, et al.
Publicado: (2020)

Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples
por: Di, Wang, et al.
Publicado: (2021)

Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition
por: Yi, Renxin, et al.
Publicado: (2020)

Randomised clinical trial of a gastrointestinal care bundle to reduce symptoms in patients with pelvic cancer undergoing chemoradiotherapy
por: White, Katherine L, et al.
Publicado: (2020)

A novel gene signature based on five immune checkpoint genes predicts the survival of glioma
por: Zhang, Wei, et al.
Publicado: (2021)

Identification of an ATP metabolism‐related signature associated with prognosis and immune microenvironment in gliomas
por: Huang, Ruoyu, et al.
Publicado: (2020)

Patient preferences for active surveillance vs standard surgery after neoadjuvant chemoradiotherapy in oesophageal cancer treatment: The NOSANO‐study
por: Hermus, Merel, et al.
Publicado: (2022)

Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy
por: Mapelli, Roberto, et al.
Publicado: (2021)

ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma
por: Li, Guanzhang, et al.
Publicado: (2018)

microRNA-217 suppressed epithelial-to-mesenchymal transition through targeting PTPN14 in gastric cancer
por: Chen, Gen, et al.
Publicado: (2020)

Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling
por: Wang, Qiangwei, et al.
Publicado: (2018)

High number of PD‐1 positive intratumoural lymphocytes predicts survival benefit of cytokine‐induced killer cells for hepatocellular carcinoma patients
por: Chang, Boyang, et al.
Publicado: (2018)

New-Onset Postoperative Seizures in Patients With Diffuse Gliomas: A Risk Assessment Analysis
por: Li, Lianwang, et al.
Publicado: (2021)

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma
por: Gleeson, Jack Patrick, et al.
Publicado: (2019)

Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy
por: Cheng, Xingyuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mmkf2to3bc1k2j4obo0n4pipsk